Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.03 USD | -1.78% | +3.67% | +9.54% |
06-06 | Morgan Stanley Adjusts Price Target on Vir Biotechnology to $15 From $12, Maintains Equal-Weight Rating | MT |
06-05 | Sector Update: Health Care Stocks Steady Premarket Wednesday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.54% | 1.53B | |
+48.42% | 57.87B | |
+41.65% | 40.25B | |
-6.65% | 39.94B | |
-5.96% | 28.54B | |
+13.00% | 26.4B | |
-20.01% | 19.33B | |
+31.71% | 12.4B | |
+0.40% | 12.23B | |
+25.05% | 12.2B |
- Stock Market
- Equities
- VIR Stock
- News Vir Biotechnology, Inc.
- Insider Sell: Vir Biotechnology